Market Overview:
The global glucocorticoid market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of autoimmune diseases, rising geriatric population, and growing demand for better treatment options. The symptomatic treatment segment is expected to dominate the market during the forecast period owing to its high usage rates for treating various autoimmune diseases. By application, the hospital pharmacy segment is expected to account for a major share of the global glucocorticoid market during the forecast period owing to increasing number of hospitals and growing demand for better treatments options.
Product Definition:
多楔带 is a type of Chinese cabbage. It is important because it is a source of vitamin C and other nutrients.
Symptomatic Treatment:
The global symptomatic treatment market size was valued at USD 6.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders & respiratory diseases along with increasing awareness about various treatments available are some growth factors for the market.
Intermediate Corticosteroid Therapies:
Intermediate corticosteroid therapies are used to treat a wide range of diseases such as asthma, allergic rhinitis, and other respiratory disorders. These medications are also used in the treatment of immune-mediated diabetes mellitus and multiple sclerosis. The global intermediate corticosteroid market is expected to grow at a lucrative rate during the forecast period owing to increasing prevalence of respiratory diseases coupled with rising awareness about these drugs among patients & healthcare professionals.
Application Insights:
The global demand for prednisone was valued at USD 5.5 billion in 2017 and is projected to grow with the advancement of the disease modifying antirheumatic drug therapies. Prednisone is used in various formulations such as oral tablets, oral suspension, intravenous injection and intranasal spray among others. The Disease Modifying Antirheumatic Drug (DMARD) segment dominated the overall market by application owing to its high usage rate across all major applications globally.
In addition, intermediate corticosteroid therapies are also expected to witness lucrative growth over the forecast period due to their rising use rate across hospital pharmacies globally coupled with retail pharmacies growing penetration rates in developing countries such as India & China over recent years.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing prevalence of rheumatoid arthritis are some factors responsible for its growth. In addition, growing awareness about early diagnosis and treatment is expected to drive the regional market during the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period owing to rising healthcare expenditure by governments as well as individuals in order to obtain better healthcare services at lower costs coupled with improving infrastructure facilities in developing countries such as India and China. These factors are expected to boost ‘Global 多楔带 Market’ revenue during the estimated time frame.
Growth Factors:
- Increasing demand from the automotive and construction industries.
- Growing popularity of electric vehicles.
- Expansion of the middle class in developing countries.
- Proliferation of online shopping platforms.
- Emergence of new transportation modes (e-commerce, ride-sharing, etc.).
Scope Of The Report
Report Attributes
Report Details
Report Title
多楔带 Market Research Report
By Type
Symptomatic Treatment, Intermediate Corticosteroid Therapies, Disease Modifying Antirheumatic Drug Therapies
By Application
Hospital Pharmacy, Retail Pharmacy, Drug Stores
By Companies
Sanofi, Pfizer, Roche, Johnson & Johnson, AbbVie, Eli Lilly, Amgen, Sobi, Bristol-Myers Squibb
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global 多楔带 Market Report Segments:
The global 多楔带 market is segmented on the basis of:
Types
Symptomatic Treatment, Intermediate Corticosteroid Therapies, Disease Modifying Antirheumatic Drug Therapies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Drug Stores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Pfizer
- Roche
- Johnson & Johnson
- AbbVie
- Eli Lilly
- Amgen
- Sobi
- Bristol-Myers Squibb
Highlights of The 多楔带 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Symptomatic Treatment
- Intermediate Corticosteroid Therapies
- Disease Modifying Antirheumatic Drug Therapies
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Drug Stores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 多楔带 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
多楔带 is a letter used in the Swedish alphabet. It is pronounced "ahks-ehk ahz".
Some of the major companies in the 多楔带 market are Sanofi, Pfizer, Roche, Johnson & Johnson, AbbVie, Eli Lilly, Amgen, Sobi, Bristol-Myers Squibb.
The ¥¤å¡¦¥€¥¸¦ market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 多楔带 Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 多楔带 Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 多楔带 Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the 多楔带 Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global 多楔带 Market Size & Forecast, 2020-2028 4.5.1 多楔带 Market Size and Y-o-Y Growth 4.5.2 多楔带 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Symptomatic Treatment
5.2.2 Intermediate Corticosteroid Therapies
5.2.3 Disease Modifying Antirheumatic Drug Therapies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Drug Stores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global 多楔带 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 多楔带 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Symptomatic Treatment
9.6.2 Intermediate Corticosteroid Therapies
9.6.3 Disease Modifying Antirheumatic Drug Therapies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Drug Stores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Symptomatic Treatment
10.6.2 Intermediate Corticosteroid Therapies
10.6.3 Disease Modifying Antirheumatic Drug Therapies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Drug Stores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Symptomatic Treatment
11.6.2 Intermediate Corticosteroid Therapies
11.6.3 Disease Modifying Antirheumatic Drug Therapies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Drug Stores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Symptomatic Treatment
12.6.2 Intermediate Corticosteroid Therapies
12.6.3 Disease Modifying Antirheumatic Drug Therapies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Drug Stores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Symptomatic Treatment
13.6.2 Intermediate Corticosteroid Therapies
13.6.3 Disease Modifying Antirheumatic Drug Therapies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Drug Stores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 多楔带 Market: Competitive Dashboard
14.2 Global 多楔带 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Pfizer
14.3.3 Roche
14.3.4 Johnson & Johnson
14.3.5 AbbVie
14.3.6 Eli Lilly
14.3.7 Amgen
14.3.8 Sobi
14.3.9 Bristol-Myers Squibb